Chromadex Corp
NASDAQ:CDXC

Watchlist Manager
Chromadex Corp Logo
Chromadex Corp
NASDAQ:CDXC
Watchlist
Price: 5.49 USD 1.48% Market Closed
Market Cap: 419.3m USD
Have any thoughts about
Chromadex Corp?
Write Note

Chromadex Corp
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Chromadex Corp
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Chromadex Corp
NASDAQ:CDXC
Revenue
$91.7m
CAGR 3-Years
12%
CAGR 5-Years
17%
CAGR 10-Years
21%
Thermo Fisher Scientific Inc
NYSE:TMO
Revenue
$42.4B
CAGR 3-Years
3%
CAGR 5-Years
11%
CAGR 10-Years
10%
Danaher Corp
NYSE:DHR
Revenue
$21.2B
CAGR 3-Years
-9%
CAGR 5-Years
6%
CAGR 10-Years
1%
Mettler-Toledo International Inc
NYSE:MTD
Revenue
$3.8B
CAGR 3-Years
1%
CAGR 5-Years
5%
CAGR 10-Years
4%
Agilent Technologies Inc
NYSE:A
Revenue
$6.5B
CAGR 3-Years
1%
CAGR 5-Years
5%
CAGR 10-Years
5%
IQVIA Holdings Inc
NYSE:IQV
Revenue
$15.3B
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
11%
No Stocks Found

Chromadex Corp
Revenue Breakdown

Breakdown by Geography
Chromadex Corp

Not Available

Breakdown by Segments
Chromadex Corp

Total Revenue: 83.6m USD
100%
Consumer Products Segment: 69.5m USD
83.2%
Ingredients Segment: 11.1m USD
13.3%
Analytical Reference Standards And Services S...: 2.9m USD
3.5%

Chromadex Corp
Glance View

Market Cap
417.4m USD
Industry
Life Sciences Tools & Services

Chromadex Corp. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. The company is headquartered in Los Angeles, California and currently employs 115 full-time employees. The company went IPO on 2007-06-25. NAD+ is a coenzyme and a regulator of cellular metabolism. The company operates through three segments: Consumer products, Ingredients, and Analytical reference standards and services segment. The Consumer products segment provides finished dietary supplement products that contain the ingredients directly to consumers as well as to distributors. The Ingredients segment develops and commercializes ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Analytical reference standards and services segment supplies phytochemical reference standards and other research and development services. Its ingredients include Tru Niagen and Immulina. The Tru Niagen is a form nicotinamide riboside (NR). NR is a member of the vitamin B3 family. Immulina is a spirulina extract.

CDXC Intrinsic Value
2.28 USD
Overvaluation 58%
Intrinsic Value
Price

See Also

What is Chromadex Corp's Revenue?
Revenue
91.7m USD

Based on the financial report for Sep 30, 2024, Chromadex Corp's Revenue amounts to 91.7m USD.

What is Chromadex Corp's Revenue growth rate?
Revenue CAGR 10Y
21%

Over the last year, the Revenue growth was 10%. The average annual Revenue growth rates for Chromadex Corp have been 12% over the past three years , 17% over the past five years , and 21% over the past ten years .

Back to Top